It has been shown that strains of normal cells which attain relatively low population densities in culture (contact inhibition of growth) inhibit each other in mixed culture (1). This interstrain inhibition is not species-specific (2). Cultured cancer cells, as well as heteroploid cells which arise "spontaneously" in culture, have in varying degree escaped from contact inhibition of growth, and under identical growth conditions attain a higher population density than their diploid counterparts. Such heteroploid cells are similarly insensitive to the growth inhibitory effects of other cell types, and the degree to which they have escaped from growth inhibition in such mixed cultures usually (but not invariably) parallels their maximum growth potential in pure culture (2).
86.~ in a humidified atmosphere of 5% CO2 in air, and colonies more than 0.7 mm in diameter were counted after 10-20 days.
Colonies growing in soft agar occasionally were examined for heterogeneity with respect to plating efficiency and heterotransplantability (see below). Monolayer cultures derived from single colonies in soft agar were replated, and the plating efficiency in soft agar determined for three successive clones. Subcultures from the third cloning were reimplanted in the hamster cheek pouch for comparison with the original culture. No significant differences were seen between the parent colonies and their derived clones, and they are not distinguished in the tables.
Tumorigenic A ctivity.--Hamster cheek pouch: As originally reported by Patt, Handler et al. (11, 12) , the cheek pouch of the Syrian hamster (Mesocricetus auratus) accepts xenogeneic transplants of some neoplastic tissues, but with few exceptions rejects xenogeneic transplants of normal tissue. This provided a useful transplantation system for the assay of the "malignant potential" of cultured cells (13) . The cell lines listed in Table I were implanted into the cheek pouches of Syrian hamsters according to methods described elsewhere (13) . All manipulations were done in complete growth medium (BME) to preserve the physiologic integrity of the cells. Log phase cultures of the parent cell lines, or of cultures derived from single colonies, were dispersed with trypsin pooled, sedimented at 50-70 g, washed three times with BME, and diluted with BME so that the desired inoculum was contained in 0.1 ml of the final suspension. The total preparation time was less than 2 hr, and more than 90-95% of the cells implanted excluded trypan blue. Both cheek pouches of each of six hamsters were everted under light Nembutal anesthesia, and the inocula were implanted into the connective tissue as an "intracutaneous" bleb. There hamsters in each group were "conditioned" with cortisone acetate (saline suspension obtained from Merck, Sharp & Dohme, West Point, Pa.), administered subcutaneously in doses of 2.5 mg twice weekly. The cheek pouches were observed once or twice weekly for at least 60 days postimplantation, and evaluated as described elsewhere (13) .
Baby hamster:
Since human cancer cells of lymphoid origin can produce tumors in normal or anti-lymphocytic serum (ALS)-treated neonatal hamsters (15, 16) , the virus-transformants were similarly tested. Each animal in two litters of newborn Syrian hamsters (less than 24 hr of age, with 8-10 animals per litter) received an intraperitoneal implant of at least 107 packed cells in a volume of 0.1 ml. One litter was treated with ALS administered intraperitoneally 3 times weekly in doses of 0.05 ml, beginning at the time of implantation. The animals were observed for tumor formation and sacrificed after 60-90 days.
Mouse inoculation: Swiss female mice, 8-10 wk of age, were injected subcutaneously into the flank with cells prepared as for hamster cheek pouch inoculation. Mice were observed for tumor formation twice weekly for 9 months. In addition, newborn mice were injected intracerebrally with 0.01 ml of a similar cell suspension, and observed for signs of cerebral involvement. When mice died after inoculation, brain tissue was examined histologically for presence of tumor tissue; and survivors were sacrificed for similar examination after 2 months.
RESULTS
Growth Capacity of Virus-Tranfformants.--As seen in the last two columns of Table I and in Fig. 1 , although transformation by viruses usually caused a significant increase in the maximum cell population achieved under the conditions of the present experiments, the magnitude of that increase varied widely. Marked increases were observed in six different lines after SV-40 transformation; but an adenovirus-transformed monkey cell showed only slightly en- hanced growth capacity. A monkey cell transformed by an adeno-SV-40 hybrid showed the small increase in maximum population density seen in the adenovirus transformant, rather than the marked increase caused by SV-40 transformation alone. Finally, although the polyoma-transformed hamster kidney cell attained an extremely high population density, the growth capacity of that virus-transformant was no greater than that of a cell (BHK-E) which had transformed "spontaneously" in culture. Table I ).
It is of interest that the virus-transformed cells were usually smaller than the parent cells. The increase in cell population effected by transformation of human, monkey, and mouse cells regularly exceeded the increase in cell protein, the amount of protein per cell in the transformants varying between 48-77 % of that of the parent cell (cf. last two columns of Table I ).
Susceptibility of Virus-transformed Cells to Growth Inhibition by Normal
Cells.--With a wide spectrum of normal and cancer cells, it had been found (2) that when small numbers of cells were superinoculated onto an essentially saturated monolayer of human or mouse cells, the ability of the superinoculated
"-~ 09 oo 09 "0 ,.~ cell to grow was usually correlated with its inherent capacity for growth: the higher the population density attained by a given cell type in pure culture, the less was its susceptibility to inhibition by other cell types. When virus-transformed cells were similarly superinoculated, the results were extremely variable (Table II) , and there was no such clear relationship between growth capacity and susceptibility to inhibition (Fig. 2) . Some of the virus-transformants, including a few with a high capacity for growth, were markedly inhibited (cf. inhibition of SV-40-transformed mouse and human cells by human diploid fibroblasts (v ~ and ~ in Fig. 2 ), of GMK-EVa and W 18-Va by mouse fibroblasts (Table II) , and of GMK-adeno by both the parent cell and by rabbit lens cells). At the other extreme, some virus-transformants, like most naturally occurring cancer cells (2), were not appreciably inhibited by contact with a saturated cell substrate (cf. polyoma-transformed BHK cell overlaid onto any other cell type: last column of Table II , and v & in Fig. 2 ). In most of the other cell combinations, the transformants were partially but significantly inhibited, although the results in repeat experiments sometimes varied widely (cf. Table  II) . As with the normal and cancer cells previously studied (2), the intercell inhibitions observed were not species-specific.
The varying susceptibility of virus-transformants to inhibition by contact with normal ceils, and the variability in the results obtained in replicate experiments with the same cell lines (Table II) ing results previously reported, ranging from marked inhibition of growth (17) (18) (19) to essentially total escape from inhibition (20, 21) .
The Serum Requirement of Normal and Virus-Transformed Cells.--In confirmation of the results of Temin (5) with chick embryo cells transformed by Rous virus, and of Holley (6) with the mouse 3T3 and its SV-40 transformant, significantly lower concentrations of serum were required for the sustained growth of most virus-transformants than for the parent cells. Although both cell types grew at essentially the same rate in high concentrations of serum (20 %), the virus-transformants generally attained higher population densities. A typical experiment is shown in Fig. 3 . \ " 
GROWTH CI~ARACTERISTICS OF VIRUS-TRANSFORMED CELLS
terms of doubling time for cell protein in log phase. Not all the virus-transformants, however, showed as striking an effect as the SV-40-transformed human lines. In Table III , the serum response of the virus-transformants has been expressed as the concentration which permits protein synthesis in log phase at half the rate observed in 20% serum. As there seen, neither the SVtransformed mouse fibroblast nor the polyoma-transformed hamster kidney cell differed significantly from the parent with respect to their serum require- See footnote:~, Table I. ment. In both cases, however, the parent cell used for comparison was a line which had transformed "spontaneously" in culture and had developed at least some of the properties of virus-transformants. Subcultures of the same line obtained from other laboratories had significantly higher serum requirements than that here studied. The monkey kidney adeno-and SV-40-transformants showed a small but significant decrease in serum requirement; and that requirement was greatly reduced in the cell transformed by the hybrid SV-40-adenovirus.
Colony Formation in Soft Agar.--It has been found in a number of laboratories (4) that virus-transformation often results in increased plating efficiency in soft agar. With the virus-transformants here studied, the number of colonies formed per 105 cells varied widely, from zero in the case of the GMK-adeno-transformant to 1565 for the hamster polyoma-transformant (Table IV) . Surprisingly, two sublines of the same hamster kidney culture (cf. Tumorigenic Activity.-Hamster cheek pouch: As indicated in the first two columns of Table V, of the nine virus-transformed cell lines here studied, 0nly the polyoma-transformed hamster kidney cell (3) was tumorigenic when implanted in the cheek pouch of the Syrian hamster. In this case, however, the parent culture was just as tumorigenic as the virus transformant. The two sublines of the parent cell used in these experiments, both of which had transformed spontaneously in terms of maximum population density and escape from contact inhibition by normal cells, were equally tumorigenic, despite the fact that one of these sublines did not grow in soft agar.
Baby hamsters and mice: Similar results were obtained when the virus-trans- Tables I-IV: 0 :e + ++ +++ Growth rclative to control (Table I) (Table III) Colonies/105 ceils in soft agar (Table  0 1-100 > 100-1000 > 1000 IV)
;~ 0, no tumor produced by 10 s cells § +, tumor produced by 10 ~ cells, but not at lower doses. In this case, however, cultures of the parent cell were also tumorigenic, and in both the hamster cheek pouch and baby hamster.
]] Parent (untransformed) culture not available for study.
formants were inoculated intraperitoneally into neonatal hamsters. The polyoma-transformed hamster kidney cell (BHK-21) was tumorigenic, as were "control" sublines of the parent cell, but none of the other virus-transformants studied produced tumors even with inocula of 106 cells (Table V) . Neither the parent BHK nor its polyoma-transformant produced tumors in newborn mice injected intracerebrally.
DISCUSSION i
Virus-transformation effects a number of major changes in cell properties, in addition to the acquired oncogenicity (22) ; and a similar pattern of change is seen in cancer cells and in spontaneous transformants in vitro (22) , as well as in cells transformed by X-ray (23) or by carcinogens (24) . The degree of association among the five such properties studied in the present experiments with eight virus-transformants is indicated in Table V . Except for tumorigenicity, all the virus-transformed lines were altered with respect to most of the properties studied. That association was, however, not invariable; and there was no clear correlation in the magnitude of the changes observed. Thus, the hybrid SV-40-adenovirus-transformant of the monkey kidney line grew to smaller population densities than either of the individual transformants (Table I) , but had a lower serum requirement than either (Table II) , and was intermediate with respect to its capacity to grow in soft agar (Table IV) .
The most prominent characteristic of the virus-transformants here studied was the failure of all but one (the polyoma-transformed baby hamster kidney cell) 2 to produce tumors on inoculation either into the cheek pouch of the hamster, into neonatal hamsters, or into the mouse brain. This may mean only that a negative result in these specific systems does not exclude "malignancy" (i.e. the ability of the transformed cell to produce a cancer) under other conditions. The fact that the transformed cells failed to produce tumors in the hamster cheek pouch or peritoneal cavity even when the immunologic mechanisms of the host had been depressed by treatment with cortisone acetate or anti-lymphocytic serum, respectively, does not wholly exclude the possibility that the generally negative results reflect heterospecific rejection of a potentially tumorigenic cell. 3 Alternatively, however, the cells may never have been malignant, or if tumorigenic when first transformed, had lost that property in the course of their serial propagation, as has been shown to occur with both naturally occurring cancer cells (25) and virus-transformants (26, 30) .
2 It is of interest that the two sublines of the BHK (hamster kidney) cell used as controls for the polyoma transforraant were just as tumorigenic as the virus transformant. The possibility that these spontaneous variants may have been transformed by an unrecognized virus can of course not be excluded. The presence of virus-like particles in clones of this strain has in fact been reported from two laboratories (28, 29) .
3 It has in fact recently been found (Dr. E. Stanbridge and Dr. F. Perkins, personal communication) that an SV40-transformed human line produced "tumor nodules" when inoculated subcutaneously into mice treated with anti-lymphocytic serum; and Dr. B. Pessac (personal communication) has similarly found that mice treated with X-ray postnataUy developed tumor nodules after subcutaneous inoculation with either the parent or SV-40-transformed 3T3 lines. Those tumors, however, regressed unless the mice were treated with antilymphocytic serum.
Be that as it may, it is apparent that an enhanced capacity for growth, relative insusceptibility to inhibition by contact with normal cells, decreased serum requirement, and enhanced capacity to grow in soft agar, did not in and of themselves endow the cells here studied with the ability to produce a tumor in hamsters or mice. Along the same lines, Rabson et al. (31) have found that SV-40-transformed monkey cells were not tumorigenic on autologous inoculation, and widely varying results have been obtained with cloned sublines of polyoma-transformed Chinese hamster cells (30) . Further, McAllister and Reed. (32) have pointed out that normal and cancerous human cells cannot be distinguished on the basis of their capacity to grow in soft agar. In the present experiments also, a number of virus-transformants which grew in soft agar failed to produce tumors on inoculation; and conversely, although two spontaneous transformants of a hamster kidney line were just as malignant as the virus-transformant, as judged by animal inoculation, one failed to form colonies in soft agar even with inocula of l0 G cells (Table IV) . The dissociation between the tumorigenicity of virus-transformants and many of the other altered properties is further evidenced by the fact that at least some of these alterations may develop before the transformants become capable of producing a tumor (21) . Conversely, revertants of polyoma-transformed hamster cells have been described which retain the capacity to produce a tumor although they have reverted toward normal with respect to most of the other changes associated with viral transformation (27) . The possibility of course remains that altered properties of virus transformants other than those here studied (e.g. a new antigenic activity, or a specific chemical change in a cell glycolipid) (36) may be the immediate determinants of their oncogenicity.
Despite the evidence that the phenotypic consequences of viral transformation here studied are neither a necessary nor sufficient condition for the ability of the transformed cells to produce a tumor in experimental animals, the fact remains that these alterations and tumorigenicity are conjoined with high frequency, not only in virus-transformants, but in spontaneous transformants and naturally occurring cancer cells as well. Further, it has been shown by two different procedures that mouse cells selected simply on the basis of their increased susceptibility to contact inhibition of growth also showed decreased tumorigenicity (33, 34) . Similarly, revertants of polyoma-transformed hamster (26) and mouse cells (31) have been described which had lost their capacity to produce a tumor and had simultaneously reverted toward normal in terms of saturation density, susceptibility to contact inhibition, and inability to clone in soft agar.
As already indicated, the fact that the phenotypic changes seen in virus transformants are not invariably associated with tumorigenicity may reflect only the inadequacy of any of the presently available animal tests of malignancy. Alternatively, however, the determinants of malignancy may be closely linked to, rather than identical with, those of the other properties of virustransformed cells here studied. In any case, as previously suggested by Federoff (35) and others, there as yet appea:r to be no generally valid in vitro criteria for predicting tumorigenicity.
SUMMARY
Virus transformants (like cancer cells, cells transformed by X-ray or carcinogens, or those which have transformed spontaneously) exhibit a number of phenotypic changes which are usually associated, and which may be lost concurrently. That association is, however, not invariable. More particularly , the altered characteristics here studied (escape from contact inhibition of growth and susceptibility to inhibition by other cells, decreased serum requirement, and ability to grow in soft agar) do not, in and of themselves, endow the cell with the capacity to produce a tumor, at least as judged by the methods of assay here used. Although the question as to whether the tumorigenicity of virus transformants is causally linked to any of these associated changes cannot be answered definitively, the evidence suggests a close linkage, rather than identity, between the determinarLts of oncogenicity and the other properties here studied. 
